Advanced Heart Failure & Transplant Cardiology
Clinician-scientist, program director, and principal investigator — helping patients, hospitals, and industry heart failure outcomes through advanced clinical care, precision medicine, and FDA-regulated clinical trials.
About

Dr. Burhan Mohamedali is Director of the Congestive Heart Failure Program at Sharp Chula Vista Medical Center and Director of the CHF Program & Research at the Cardiovascular Institute of San Diego (CVISD), where he leads clinical care, program development, and research initiatives in advanced heart failure. He holds an affiliate faculty appointment at UC San Diego.
Prior to relocating to San Diego, Dr. Mohamedali led the heart transplant program at Rush University Medical Center in Chicago, gaining deep experience in advanced heart failure and transplantation within a major academic medical center. Since then, he has continued to lead heart failure and transplant programs across both academic and private practice settings, giving him a broad perspective on how CHF care can be delivered effectively across different institutional models. He maintains active industry collaborations spanning gene and cell therapy, precision medicine, and device-based therapeutics, keeping his practice at the forefront of emerging treatment modalities.
His particular area of focus is the design and implementation of heart failure programs and systems of care—building the infrastructure, protocols, and clinical pathways that allow hospital systems to deliver high-quality CHF management from the ground up. This work is especially oriented toward resource-limited environments, where he applies his experience to strengthen care delivery in settings that often face the greatest systemic challenges.
Dr. Mohamedali has published more than 25 peer-reviewed papers, contributed a book chapter on cardio-nephrology, and lectured internationally across the U.S., China, Tanzania, and India.
Experience
2017 – Present
Director, Congestive Heart Failure Program & Research
Expanded access to genomic biomarker-driven therapeutics and device-based clinical trials in a private practice setting.
2021 – Present
Director, Congestive Heart Failure Program
Clinical pathways, digital monitoring, and biomarker-driven care. HFSA Outstanding Heart Failure Team Award (2025); Sharp C.O.R.E. Award (2024).
2022 – Present
Affiliate Faculty
Collaborator in multi-center genomic and translational cardiovascular research.
2014 – 2017
Medical Director, Advanced Heart Failure & Transplant Program
Directed inpatient/outpatient HF and transplant programs, LVAD program, and integration of novel device and genomic therapies.
Focus
Research
Principal investigator on multiple FDA-regulated device, cell therapy, and pharmacotherapy trials, with 25+ peer-reviewed publications in advanced heart failure, LVAD outcomes, and transplant cardiology.
Plus 20+ additional peer-reviewed publications and a book chapter in Cardio-nephrology: Confluence of the Heart and Kidney in Clinical Practice.
Recognition
Latest Recognition
Bronze Achievement Award, 2026
The American Heart Association recognizes Sharp Chula Vista Medical Center for continued success in using the Get With The Guidelines® program to deliver evidence-based heart failure care.

Featured Post
Consulting
Hospitals do not need another heart failure lecture. They need a practical, multidisciplinary system that reliably moves patients from hospitalization to stability — the same approach behind an HFSA-recognized program.
Development of heart failure service lines, transitional clinics, ED pathways, LVAD programs, and multidisciplinary care models.
Strategies to improve GDMT adoption, reduce avoidable readmissions, and meet national quality standards — informed by an HFSA award-winning program.
PI experience across FDA-regulated device, cell therapy, and pharmacotherapy trials; advisory work in gene/cell therapy and precision cardiovascular medicine.
Education
Dr. Mohamedali is available for grand rounds, hospital leadership sessions, physician education, advisory boards, and conferences on heart failure care delivery, GDMT implementation, cardiogenic shock, LVAD/transplant, and value-based cardiovascular care.
Languages: English, Swahili, Hindi (fluent); Spanish (conversational).
“The future of heart failure care is not only better medication — it is better systems of care.”
Contact
For clinical, consulting, speaking, research, or advisory inquiries:
burhan@BurhanMohamedali.comSan Diego, California